2,022
Views
4
CrossRef citations to date
0
Altmetric
Original Articles: Medical Oncology

Delta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab

, & ORCID Icon
Pages 475-481 | Received 21 May 2020, Accepted 23 Oct 2020, Published online: 16 Nov 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.